We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

1 hedge funds and large institutions have $3.62M invested in Seelos Therapeutics, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

20% less capital invested

Capital invested by funds: $4.52M → $3.62M (-$902K)

85% less call options, than puts

Call options by funds: $61K | Put options by funds: $404K

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$61K
Puts
$404K
Net Calls
-$343K
Net Calls Change
-$24K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
NSIM
North Star Investment Management
Illinois
-$240K
2
Nomura Holdings
Nomura Holdings
Japan
-$44K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.9M – – –
California Public Employees Retirement System
2
California Public Employees Retirement System
California
$539K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$263K – – –
BFA
4
BlackRock Fund Advisors
California
$211K – – –
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$168K – – –
Bank of New York Mellon
6
Bank of New York Mellon
New York
$109K – – –
Northern Trust
7
Northern Trust
Illinois
$92K – – –
RG
8
Rathbones Group
United Kingdom
$73K – – –
Deutsche Bank
9
Deutsche Bank
Germany
$68K – – –
U
10
UBS
Switzerland
$47K – – –
RCM
11
Rotella Capital Management
Washington
$31K – – –
GC
12
Guggenheim Capital
Illinois
$26K – – –
State Street
13
State Street
Massachusetts
$24K – – –
BA
14
BlackRock Advisors
Delaware
$18K – – –
AIG
15
American International Group
New York
$11.8K – – –
Group One Trading
16
Group One Trading
Illinois
$9K – – –
WA
17
WFG Advisors
Texas
$9K – – –
Citadel Advisors
18
Citadel Advisors
Florida
$7K – – –
Citigroup
19
Citigroup
New York
$5K – – –
TRCT
20
Tower Research Capital (TRC)
New York
$3K – – –
Bank of America
21
Bank of America
North Carolina
$2K – – –
HDIM
22
Hanson & Doremus Investment Management
Vermont
$2K – – –
Wells Fargo
23
Wells Fargo
California
$2K – – –
HI
24
Hudock Inc
Pennsylvania
$1K – – –
Manulife (Manufacturers Life Insurance)
25
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2 – – –
1
2

SEEL Hedge Fund Activity: Q3 2013 in Review

1 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q3 2013, worth a combined $3.62M — down 20% from $4.52M a quarter earlier.

Fund positioning in SEEL was balanced in Q3 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was North Star Investment Management, cutting an estimated $240K.

  • 1 institutional investor held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $3.62M of Seelos Therapeutics, Inc. Common Stock stock for Q3 2013, down 20% quarter-over-quarter.
  • 0 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q3 2013 and 0 closed out.
  • The largest Seelos Therapeutics, Inc. Common Stock seller in Q3 2013 was North Star Investment Management, an estimated $240K sold.

Based on aggregated 13F filings for Q3 2013.